Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Age ≥ 18 years;
• Brazilian resident;
• Symptomatica COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment.
Locations
Other Locations
Brazil
Inova Medical
RECRUITING
Cachoeirinha
Contact Information
Primary
Maicon Falavigna, MD, PhD
maicon@inovamedical.com.br
+5551994408818
Backup
Régis G Rosa, MD, PhD
regis@inovamedical.com.br
+5551991303877
Time Frame
Start Date: 2023-07-21
Estimated Completion Date: 2025-07-31
Participants
Target number of participants: 1694
Treatments
Individuals with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil
Related Therapeutic Areas
Sponsors
Collaborators: Merck Sharp & Dohme LLC
Leads: Inova Medical